- Home
- ARAY vs NTRB Comparison
ARAY vs NTRB Comparison
Compare ARAY & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARAY | NTRB |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.2M | 44.2M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARAY | NTRB |
|---|---|---|
| Price | $0.46 | $3.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 5.8K |
| Earning Date | 05-06-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $4.58 | $3,394.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $3.42 |
| 52 Week High | $2.10 | $11.68 |
Technical Indicators
Market Signals| Indicator | ARAY | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 52.02 | 37.63 |
| Support Level | $0.34 | $3.64 |
| Resistance Level | $0.48 | $4.31 |
| Average True Range (ATR) | 0.04 | 0.15 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 51.06 | 0.00 |
Price Performance
Historical ComparisonAbout ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.